The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,796.00
Bid: 1,788.00
Ask: 1,796.00
Change: -50.00 (-2.71%)
Spread: 8.00 (0.447%)
Open: 1,882.00
High: 1,882.00
Low: 1,762.00
Prev. Close: 1,846.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Sep 2018 17:27

RNS Number : 0305B
Genus PLC
17 September 2018
 

17 September 2018

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that, further to the vesting of conditional nil-cost options on 14 September 2018 under the Genus 2014 Performance Share Plan (the 'PSP') and the Genus Deferred Share Bonus Plan (the 'DSBP') as listed in table A and table B below respectively, a member of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 14 September 2018 on the London Stock Exchange, with income tax and social security liabilities due on the PSP exercise being deducted from the sale proceeds and the balance of funds retained, and income tax and social security liabilities due on the DSBP exercise being offset by ordinary shares sold and the balance of ordinary shares retained.

 

In addition, further to the vesting of conditional shares on 14 September 2018 under the Genus 2014 Performance Share Plan (the 'PSP') as listed in table C below, a member of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 14 September 2018 on the London Stock Exchange, with income tax and social security liabilities due on the release being deducted from the sale proceeds and the balance of funds retained.

 

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the number of nil-cost options exercised and ordinary shares sold on 14 September 2018 and also the number of conditional shares released and ordinary shares sold on 14 September 2018.

 

For further information please contact:

 

Genus:

Josie Havita, Interim Deputy Company Secretary Tel: +44 (0)1256 347100

 

 

Table A - GELT 2014 Performance Share Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jonathan Lightner

2.

Reason for the notification

a.

Position/status

Chief Scientific Officer & Head of Genus R&D

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 14,375 nil-cost options under the PSP.

 

c.

Price(s) and volume(s)

Price(s)

 

0p

Volume(s)

 

14,375

 

d.

Aggregated information

· Aggregated volume

· Price

Average Price(s)

 

0p

Volume(s)

 

14,375

 

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

Outside a trading venue.

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

GB0002074580

b.

Nature of the transaction

Sale of 14,375 shares arising from the exercise of nil-cost options under the PSP.

c.

Price(s) and volume(s)

Price(s)

 

2,506p

Volume(s)

 

14,375

 

d.

Aggregated information

· Aggregated volume

· Price

Average Price(s)

 

2,506p

Volume(s)

 

14,375

 

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table B - GELT Deferred Share Bonus Plan Exercise 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jonathan Lightner

2.

Reason for the notification

a.

Position/status

Chief Scientific Officer & Head of Genus R&D

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 3,850 nil-cost options under the DSBP.

 

c.

Price(s) and volume(s)

Price(s)

 

0p

Volume(s)

 

3,850

 

d.

Aggregated information

· Aggregated volume

· Price

Average Price(s)

 

0p

Volume(s)

 

3,850

 

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

Outside a trading venue.

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

b.

Nature of the transaction

Sale of 1,301 shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise.

c.

c.

Price(s) and volume(s)

Price(s)

 

2,505.5266p

Volume(s)

 

1,301

 

d.

d.

Aggregated information

· Aggregated volume

· Price

Price(s)

 

2,505.5266p

Volume(s)

 

1,301

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table C - GELT 2014 Performance Share Plan Release

5.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Angelle Rosata

6.

Reason for the notification

a.

Position/status

Group Human Resources Director

 

b.

Initial notification

/Amendment

Initial notification

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Release of 1,499 conditional shares under the PSP.

 

c.

Price(s) and volume(s)

Average price(s)

 

0p

Total volume(s)

 

1,499

 

d.

Aggregated information

· Aggregated volume

· Price

 

Average price(s)

 

0p

Total volume(s)

 

1,499

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

Outside a trading venue.

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

e.

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

f.

b.

Nature of the transaction

Sale of 1,499 shares arising from the release of conditional shares under the PSP.

 

g.

c.

Price(s) and volume(s)

Price(s)

 

2,500.0p

Total volume(s)

 

1,499

 

h.

d.

Aggregated information

· Aggregated volume

· Price

 

Average price(s)

 

2,500.0p

 

Total volume(s)

 

1,499

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUBUNRWVAKAAR
Date   Source Headline
2nd Jun 20177:00 amRNSTotal Voting Rights
1st Jun 20177:05 amRNSUpdate Regarding The Milk Pension Fund
2nd May 20173:00 pmRNSTotal Voting Rights
12th Apr 20174:48 pmRNSDirector/PDMR Shareholding
3rd Apr 20172:00 pmRNSTotal Voting Rights
3rd Apr 20177:00 amRNSSUCCESSFUL LEGAL OUTCOME FOR GENUS
15th Mar 20175:15 pmRNSDirector/PDMR Shareholding
15th Mar 201712:00 pmRNSDirector Declaration
1st Mar 201710:09 amRNSDirector/PDMR Shareholding
23rd Feb 20174:20 pmRNSCorrection of Record Date
23rd Feb 20177:00 amRNSInterim Results
23rd Feb 20177:00 amRNSAcquisition and strategic partnership
7th Feb 20174:00 pmRNSHolding(s) in Company
1st Feb 20172:00 pmRNSBlock listing Interim Review
13th Dec 20163:39 pmRNSDirector/PDMR Shareholding
1st Dec 20162:00 pmRNSTotal Voting Rights
17th Nov 20162:01 pmRNSResult of AGM
17th Nov 20167:00 amRNSAGM - Trading Update
1st Nov 20164:00 pmRNSTotal Voting Rights
31st Oct 20163:47 pmRNSAnnual Report and Annual General Meeting
26th Oct 20164:00 pmRNSHolding(s) in Company
11th Oct 20164:08 pmRNSDirector/PDMR Shareholding
3rd Oct 20166:09 pmRNSBlock Listing and Additional Listing
3rd Oct 20165:57 pmRNSTotal Voting Rights
29th Sep 20165:00 pmRNSDirector/PDMR Shareholding
15th Sep 20165:00 pmRNSDirector/PDMR Shareholding
8th Sep 20165:18 pmRNSDirector/PDMR Shareholding
8th Sep 20167:00 amRNSPreliminary Results
7th Sep 20167:00 amRNSNON-EXECUTIVE DIRECTOR RETIREMENT
1st Sep 20164:17 pmRNSTotal Voting Rights
15th Aug 20167:00 amRNSFINAL JURY DECISIONS IN US LITIGATION
12th Aug 20167:00 amRNSFURTHER DECISIONS IN US LITIGATION
11th Aug 20167:00 amRNSFIRST DECISIONS IN US ANTI-TRUST LITIGATION
1st Aug 20169:20 amRNSBlock listing Interim Review
1st Aug 20169:09 amRNSTotal Voting Rights
27th Jul 20167:00 amRNSSigns exclusive licence for tech. to combat BRD
15th Jul 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
1st Jul 20163:10 pmRNSTotal Voting Rights
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20162:00 pmRNSTotal Voting Rights
18th May 20167:00 amRNSExclusive Licence for Leading Gene Editing Tech
3rd May 20162:29 pmRNSTotal Voting Rights
13th Apr 20163:13 pmRNSDirector/PDMR Shareholding
1st Apr 20163:31 pmRNSDirector/PDMR Shareholding
9th Mar 20165:03 pmRNSDirector/PDMR Shareholding
4th Mar 20169:30 amRNSBOARD APPOINTMENT
3rd Mar 20162:00 pmRNSDirector/PDMR Shareholding
1st Mar 20165:17 pmRNSDirector/PDMR Shareholding
23rd Feb 20167:00 amRNSINTERIM RESULTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.